PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9321518-1 1997 Caffeine and 7,8-benzoflavone activate CYP3A2 in rat liver microsomes. Caffeine 0-8 cytochrome P450, family 3, subfamily a, polypeptide 2 Rattus norvegicus 39-45 9321518-1 1997 Caffeine and 7,8-benzoflavone activate CYP3A2 in rat liver microsomes. alpha-naphthoflavone 13-29 cytochrome P450, family 3, subfamily a, polypeptide 2 Rattus norvegicus 39-45 9321518-5 1997 The involvement of cytochrome b5 in the formation of N-acetyl-p-benzoquinone imine (NAPQI) was implicated through a synergistic effect of NADH on the NADPH-supported reaction. N-acetyl-4-benzoquinoneimine 53-82 cytochrome b5 type A Rattus norvegicus 19-32 9321518-5 1997 The involvement of cytochrome b5 in the formation of N-acetyl-p-benzoquinone imine (NAPQI) was implicated through a synergistic effect of NADH on the NADPH-supported reaction. N-acetyl-4-benzoquinoneimine 84-89 cytochrome b5 type A Rattus norvegicus 19-32 9321518-5 1997 The involvement of cytochrome b5 in the formation of N-acetyl-p-benzoquinone imine (NAPQI) was implicated through a synergistic effect of NADH on the NADPH-supported reaction. NAD 138-142 cytochrome b5 type A Rattus norvegicus 19-32 9321518-5 1997 The involvement of cytochrome b5 in the formation of N-acetyl-p-benzoquinone imine (NAPQI) was implicated through a synergistic effect of NADH on the NADPH-supported reaction. NADP 150-155 cytochrome b5 type A Rattus norvegicus 19-32 9321518-6 1997 Anti-cytochrome b5, but not anti-cytochrome P450 reductase IgG, diminished the activation effect of caffeine on NAPQI formation. Caffeine 100-108 cytochrome b5 type A Rattus norvegicus 5-18 9321518-6 1997 Anti-cytochrome b5, but not anti-cytochrome P450 reductase IgG, diminished the activation effect of caffeine on NAPQI formation. N-acetyl-4-benzoquinoneimine 112-117 cytochrome b5 type A Rattus norvegicus 5-18 9321518-8 1997 The impairment of NAPQI formation by cytochrome b5 antibody suggests that cytochrome P450 activation by caffeine but not 7,8-benzoflavone is mediated in part through enhancement of the transfer of the second electron to cytochrome P450 from cytochrome b5. N-acetyl-4-benzoquinoneimine 18-23 cytochrome b5 type A Rattus norvegicus 37-50 9321518-8 1997 The impairment of NAPQI formation by cytochrome b5 antibody suggests that cytochrome P450 activation by caffeine but not 7,8-benzoflavone is mediated in part through enhancement of the transfer of the second electron to cytochrome P450 from cytochrome b5. Caffeine 104-112 cytochrome b5 type A Rattus norvegicus 37-50 9321518-8 1997 The impairment of NAPQI formation by cytochrome b5 antibody suggests that cytochrome P450 activation by caffeine but not 7,8-benzoflavone is mediated in part through enhancement of the transfer of the second electron to cytochrome P450 from cytochrome b5. Caffeine 104-112 cytochrome b5 type A Rattus norvegicus 241-254